Fig 5. Average cost of 1 day of treatment with NCD medicines and consumption levels, 2019–2021.
The data refer to the sum of consumption of medicines in DDDs used in treatment of diabetes (A10), in CVDs (B01, C01-C03, C07-C10), asthma and COPD (J01, R03), Cancer (hormone therapy for breast and prostate cancer–L02), epilepsy (N03), mental disorders (N05B, N06A) and weighted average prices.
